Tacalyx

is a Germany-based biotechnology company that researches and develops novel anti-TACA immunotherapies for the treatment of cancer...
Read more
Tacalyx CEO: Peter Sondermann

CEO

Peter Sondermann

CEO Approval Rating

70/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$15.2M

Tacalyx Competitors

1iOmx
2Breakpoint Therapeutics
3PSI CRO AG
4Celleron Therapeutics
5ODS

Trending Companies